Market Pulse LIVECAST Terminal Brief Politics Macro Calendar

More

Stocks About Why SquawkNews Newsroom Schedule Prediction Markets Disclosure Wire Crypto Search

Market Pulse LIVECAST

Menu

Home Market Pulse LIVECAST Terminal Brief Politics Macro Calendar Stocks About Why SquawkNews Newsroom Schedule Prediction Markets Disclosure Wire Crypto Search

Live News REGULATION L impact Jul 14, 2026, 12:14 PM UTC

Agilent receives FDA approval for PD-L1 IHC 28-8 pharmDx assay

Agilent Technologies (A)...

SquawkNews Newsroom

Agilent Technologies (A)...

Use this page

Share or save this market-moving headline as a permanent SquawkNews URL. The live feed continues at /news.

Open live news feed Browse news archive Browse news categories Search related coverage

Related tickers

BMY

Related stories

NWGL Cl workshop group: enters securities purchase agreement for private placement of 12.3mln units at $0.20 per unit - SEC filing - Offerin NWGL Cl workshop group: enters securities purchase agreement for private placement of 12.3mln units at $0.20 per unit - SEC filing - Offering expected to raise about $2.46mln in gr L impact | REGULATION | Jul 14, 2026, 01:13 PM UTC Agilent Wins FDA Approval for PD-L1 Test to Guide Bristol Myers' Opdivo Use in GI Cancers Agilent Technologies (A) said Tuesday the US Food and Drug Administration approved its PD-L1 IHC 28-8 pharmDx assay as a companion diagnostic for Bristol Myers Squibb's Opdivo and L impact | REGULATION | Jul 14, 2026, 12:52 PM UTC ACHV Cytisinicline's CRL was released by FDA, and no surprises with Q426 resubmission still planned; BUY, $13 PT @ Canaccord ACHV Cytisinicline's CRL was released by FDA, and no surprises with Q426 resubmission still planned; BUY, $13 PT @ Canaccord L impact | REGULATION | Jul 14, 2026, 12:17 PM UTC Deal priced today • ERAS 31.4M share Spot Secondary, priced at $17.50, by JPMC, MSCO, JEFF & Evercore Deals to be priced today • QTTB $200M Deal priced today • ERAS 31.4M share Spot Secondary, priced at $17.50, by JPMC, MSCO, JEFF & Evercore Deals to be priced today • QTTB $200M Secondary announced last night, shares & L impact | REGULATION | Jul 14, 2026, 12:15 PM UTC RMAX Re/max holdings - U.S. DOJ grants early termination of hsr act waiting period on July 13, 2026 - SEC filing RMAX Re/max holdings - U.S. DOJ grants early termination of hsr act waiting period on July 13, 2026 - SEC filing L impact | REGULATION | Jul 14, 2026, 12:10 PM UTC APMD apnimed announces FDA Acceptance of new drug application for ad109, an investigational oral pill to treat adults with obstructive Sleep APMD apnimed announces FDA Acceptance of new drug application for ad109, an investigational oral pill to treat adults with obstructive Sleep apnea (osa) Apnimed - FDA sets pdufa ta L impact | REGULATION | Jul 14, 2026, 12:00 PM UTC

SQUAWK/NEWS

Real-time financial news agency. Market-moving headlines, macro, politics, filings and audio squawk built for traders.

Product

LiveCast
Terminal
Brief
Macro
Calendar
Search

Company

About
Why SquawkNews
Newsroom
Editorial Standards
Corrections
Contact

© 2026 SquawkNews robots / sitemap SquawkNews publishes factual market information and context. It is not investment advice and does not provide trade recommendations.